The 2017 Fidenato case and the 2015 Directive: The curious case of GMOs in Europe

AuthorAlessandra Guida
Published date01 July 2020
DOIhttp://doi.org/10.1111/reel.12325
Date01 July 2020
RECIEL. 2020;29:291–300. wileyonlinelibrary.com/journal/reel
|
  291© 2020 John Wile y & Sons Ltd
1 | INTRODUCTION
In the 2017 Fidenato case, the Cour t of Justice of the Euro pean
Union (CJEU) dec ided in favour of a farm er, Giorgio Fidenato, al-
lowing him to cultivate genetically modified (GM) Maize 810, de-
spite the implementation of a national decree prohibiting such
cultivation in Italy.1 This is not the first cas e in which a governmen-
tal request to b an the cultivation of genet ically modified org anisms
(GMOs) in light of the pre cautionary prin ciple has been rejected by
the Court of Jus tice. Already in 2 007, Austria provided noti ce to
the European Co mmission about a draft l aw of Upper Austria (Lan d
Oberösterreich) regarding a ban that aimed to prohibit the cultiva-
tion of seed and pl anting material comp osed of, or containing ,
GMOs and the bre eding and releas e of transgenic animal s.2 The
ban aimed to safeg uard the environment a nd natural biodivers ity of
the province of Upp er Austria from the harmful ef fects of GMOs.
However, the Austrian gove rnment was denied i ts request to ban
GM cultivation s on the province of Uppe r Austria mainly b ecause
the Court of Jus tice assessed th e national reques t to be scientifi-
cally unfounded.3
By contrast, Fidenato was t he first case to be d ecided by the
Court of Just ice after the ad option of Directi ve 2015/412, which
allows Member St ates to ‘restrict o r prohibit the cult ivation of ge-
netically modified organisms (GMOs) in their territory’.4 To date,
there are no stu dies analysing the Fidenato case in light of t he 2015
Directive. T he reason might lie in th e fact that this c ase does not
concern measur es adopted on the legal basis of t he Directive’s new
Article 26b. Fur thermore, the Directive , which was invoked by the
Italian governm ent to support it s request, coul d not apply ratione
temporis to the Fidenato case.5 These are arguably also the reasons
why the Court of J ustice did not apply t he 2015 Directive to t he
2017 ca se.
1Case C-111/16 , Giorgio Fidenato and Others, ECLI:EU:C:2017:676 (Fidenato).
2Joined Case s 439/05 P and 454/05 P, Land Ober österreich an d Republic of Aus tria v
Commission of the European Communities, ECLI:EU:C:2007:510 (Austrian case) pa ra 6.
3ibid paras 66 a nd 74.
4Directive ( EU) 2015/412 amending Dir ective 2001/18/EC a s regards the pos sibility for
the Member St ates to restri ct or prohibit t he cultivatio n of genetically m odified
organisms (G MOs) in their ter ritory [2015] OJ L68/1 (D irective 2015/412) ar t 26b.
5While the 2015 D irective ente red into force onl y in April 2015, th e Italian prohi bition
dates back to Ju ly 2013.
Received: 27 Sept ember 2019 
|
  Revised: 12 Febru ary 2020 
|
  Accepted: 20 Febru ary 2020
DOI: 10 .1111/reel .12325
ORIGINAL ARTICLE
The 2017 Fidenato case and the 2015 Directive: The curious
case of GMOs in Europe
Alessandra Guida
Correspondence
Email: alessandra.guida@mq.edu.au The 2017 Fidenato case is the first leg al dispute on the cultivatio n of genetically
modified organi sms (GMOs) decided by the Cour t of Justice of the European Union
after the adoptio n of Directive 2015/412. The Directive allows for th e exclusion of
genetically modi fied cultivation from a n ational territory on g rounds unrelated to
scientific uncer tainty. As in the 2007 Austrian ca se, in Fidenato the Court of Justice
rejected the pre cautionary req uest from Italy to ban t he cultivation of GMOs. T he
ruling centres on the a rgument of a ban being scient ifically unfounded . This article
discusses how the lack of h armonization betwe en the European jurispr udence on
the cultivation of GMOs and recent normative amendments introduced through the
2015 Directive affe cts the regulatory auto nomy of Member States in adopting mea s-
ures that ensure the pr otection of human health and the environ ment (i.e. biosafety)
from the potential har mful effects posed by GMOs.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT